Ajing M. Xu
1665 Kongjiang Road
Shanghai, 200092, China
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Molecular Mechanisms and Targeted Therapies of PTPN2 in Metabolic Diseases: A Review.
Journal: Biomolecules
Published: May 12, 2026
Phosphatase PTP-4 downregulates ATLN-1-mediated host defense against Pseudomonas aeruginosa infection in Caenorhabditis elegans.
Journal: Frontiers in pharmacology
Published: February 05, 2026
The Histone-Lysine N-Methyltransferase (KMT2) Family in Health and Disease.
Journal: MedComm
Published: June 09, 2025
Wogonoside ameliorates oxidative damage in tubular epithelial cells of diabetic nephropathy by modulating the HNF4A-NRF2 axis.
Journal: International immunopharmacology
Published: January 11, 2025
Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 03, 2024
Baicalin alleviates lipid metabolism disorders in diabetic kidney disease via targeting FKBP51.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 16, 2024
Mitigating neurodegenerative diseases: the protective influence of baicalin and baicalein through neuroinflammation regulation.
Journal: Frontiers in pharmacology
Published: May 08, 2024
Insights into spinal muscular atrophy from molecular biomarkers.
Journal: Neural regeneration research
Published: January 17, 2024
Predicting fracture risk for elderly osteoporosis patients by hybrid machine learning model.
Journal: Digital health
Published: November 18, 2023
Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 14, 2023
Last Updated: 09/26/2026